Drug Target Review – Issue 2 2022 By Drug Target Review 14 June 2022 Shares 8 Share this post Share via Facebook Like Twitter Pinterest LinkedIn Digg Del Tumblr VKontakte Print Email Reddit Buffer Love This Weibo Pocket Xing Odnoklassniki WhatsApp Meneame Blogger Amazon Yahoo Mail Gmail AOL Newsvine HackerNews Evernote MySpace Mail.ru Viadeo Line Flipboard Comments Yummly SMS Viber Telegram Subscribe Skype Facebook Messenger Kakao LiveJournal Yammer Edgar Fintel Mix Instapaper Copy Link In this issue are articles focusing on a novel stem cell therapy for hearing loss, how a non-linear chiroptical effect could aid drug discovery and the advantages of cryo-electron tomography for imaging research. Also included are pieces on gene therapy, spheroids and genomics. Included in this issue: SCREENING Miniaturising organoid drug screens using nanofibrillar cellulose hydrogels Dr Tijmen Booij and Dr Christian Stirnimann, ETH Zurich BIOANALYSIS A multi-step analysis including GCI reveals novel insight into LPS translocation Dr Michael Hennig, leadXpro IMAGING The bigger picture: innovation in microscopy Dr Peter O’Toole, University of York CELL & GENE THERAPY Providing new hope for rare disease using non-viral gene therapy Brent Warner, Poseida Therapeutics ANTIBODIES Antibody pipelines – the pharma perspective Dr Erik Vernet, Novo Nordisk GENOMICS Whole genome sequencing in cancer research Dr Andrea Degasperi, University of Cambridge STEM CELLS New immune targets to improve survival from sepsis Daniel Morales-Mantilla, Dr Robin Parihar and Dr Katherine King, Baylor College of Medicine